etectRx™, Inc. is a Digital Health company that has developed a patented ingestible event marker (the ID-Cap™ System) that provides real-time, dose-level ingestion event verification. The ID-Cap System can be used by patients, healthcare providers, health systems, payers, and research organizations to track ingestion events and to measure, monitor and improve medication adherence and can also be used by pharmaceutical companies to develop Digital Medicine.
The ID-Cap System is a medical device that has been cleared by the FDA as an ingestible event marker. The ID-Cap System utilizes a proprietary in vivo communications technology that emits a very low power radio frequency (RF) digital message from within the patient after a sensor is ingested and detects the signal using a wearable Reader. The ID-Cap System is comprised of the ID-Capsule which contains the ingestible sensor (the ID-Tag), the wearable ID-Cap Reader, and related software which allows data to be displayed for the patient and clinician.
etectRx has successfully completed 14 IRB-approved clinical trials, including three NIH-sponsored trials, demonstrating the feasibility, effectiveness, and safety of the device in over 5,100 ingestions and 257 study participants.
The ID-Cap System is a medical device that has been cleared by the FDA as an ingestible event marker. The ID-Cap System utilizes a proprietary in vivo communications technology that emits a very low power radio frequency (RF) digital message from within the patient after a sensor is ingested and detects the signal using a wearable Reader. The ID-Cap System is comprised of the ID-Capsule which contains the ingestible sensor (the ID-Tag), the wearable ID-Cap Reader, and related software which allows data to be displayed for the patient and clinician.
etectRx has successfully completed 14 IRB-approved clinical trials, including three NIH-sponsored trials, demonstrating the feasibility, effectiveness, and safety of the device in over 5,100 ingestions and 257 study participants.
Location: United States, Florida, Gainesville
Employees: 11-50
Founded date: 2009
Mentions in press and media 5
| Date | Title | Description |
| 04.05.2021 | etectRx Announces Launch of MyTPill Study to Address Medication Adherence Among HIV+ Prescription Opioid Users | |
| 08.04.2021 | Digital therapy devs are bringing smart pills back, but consumers may not be ready | Digital therapeutics (DTx) company Pear struck a bundle of partnerships to build out its prescription digital therapy platform, including a tie-up with smart pill maker EtectRx to combine DTx with medication adherence tech that includes an ... |
| 14.01.2021 | ‘Smart pill’ startup etectRx strikes partnership with Pear Therapeutics | etectRx’s technology measures medication adherence. A tiny sensor embedded in each pill is activated when it reaches the patient’s stomach. Photo credit: etectRx After joining etectRx as CEO in August, Valerie Sullivan faced a big task. Com... |
| 21.12.2018 | За параноиками реально следят, но не так тщательно, как за сахаром в крови. Цифровая терапевтика. Часть вторая | Цифровая таблетка от компании Proteus WSJ 0 Обсудить 388 просмотров Продолжение. Часть первая. Представьте, что у вашего собеседника параноидальная шизофрения, и он говорит вам, что за ним следят, с помощью миниатюрного передатчика в его же... |
| - | ‘Smart pill’ startup etectRx strikes partnership with Pear Therapeutics | etectRx’s technology measures medication adherence. A tiny sensor embedded in each pill is activated when it reaches the patient’s stomach. Photo credit: etectRx After joining etectRx as CEO in August, Valerie Sullivan faced a big task. Com... |